UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates

Gillespie, SH; Basu, S; Dickens, AL; O'Sullivan, DM; McHugh, TD; (2005) Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J ANTIMICROB CHEMOTH , 56 (2) 344 - 348. 10.1093/jac/dki191. Green open access

[thumbnail of Flouroquinolones_on_M._fort_published3.pdf]
Preview
PDF
Flouroquinolones_on_M._fort_published3.pdf

Download (93kB)

Abstract

Objectives: Fluoroquinolones have found a place in the management of mycobacterial diseases including tuberculosis. It has been previously shown that subinhibitory concentrations of quinolones increase the mutation rate in Escherichia coli and staphylococci. The purpose of this study is to extend this observation to mycobacteria and to quantify mutation rates.Methods: The mutation rate in Mycobacterium fortuitum to ciprofloxacin, levofloxacin, moxifloxacin, rifampicin, erythromycin and gentamicin resistance was determined when grown with and without various sub-MIC concentrations of ciprofloxacin.Results: M. fortuitum exposed to 1/2 MIC ciprofloxacin had an increase in the mutation rate of between 72- and 120-fold when selected on quinolones or other anti mycobacterial antibiotics. Smaller, but significant increases in mutation rate were seen when the organism was exposed to lower concentrations (1/4 MIC and 1/8 MIC).Conclusions: These data show that sub-MIC concentrations of fluoroquinolone significantly increase mutation rates and these data suggest that care must be taken to ensure that bacteria are not exposed to subinhibitory concentrations when adding quinolones to a regimen used to treat mycobacterial infection.

Type: Article
Title: Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/jac/dki191
Keywords: fluoroquinolones, mycobacteria, quinolones, M. fortuitum, RANDOMIZED CONTROLLED TRIAL, PULMONARY TUBERCULOSIS, ESCHERICHIA-COLI, DRUG-RESISTANCE, IN-VITRO, PSEUDOMONAS-AERUGINOSA, STAPHYLOCOCCUS-AUREUS, BACTERICIDAL ACTIVITY, HIGH-FREQUENCY, MOXIFLOXACIN
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/1034
Downloads since deposit
324Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item